Related Experiment Video
Updated: Feb 16, 2026
07:58
Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
Published on: November 23, 2017
8.2K
Current management of lipoblastoma
Emmanuelle Séguier-Lipszyc1, Artur Baazov2, Suzanna Fichman3
1Department of Pediatric and Adolescent Surgery, Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Kaplan St 14, 4920235, Petah Tikva, Israel. seguiere@gmail.com.
European Journal of Pediatrics
|December 16, 2017
Summary
Lipoblastoma, a rare benign fatty tumor in children, requires complete surgical resection. Long-term follow-up is crucial due to potential local recurrences, even years after initial treatment.
Area of Science:
- Pediatric Oncology
- Surgical Pathology
- Medical Imaging
Background:
- Lipoblastoma is a rare, benign tumor originating from embryonic fat cells.
- Typically diagnosed in children under three years old, it can appear on the trunk or extremities.
Purpose of the Study:
- To present a series of pediatric lipoblastoma cases.
- To evaluate treatment outcomes and follow-up strategies for lipoblastoma.
Main Methods:
- Retrospective review of 10 children with lipoblastoma treated between 2011 and 2016.
- Surgical resection of tumors, with follow-up ranging from 1 to 5 years.
Main Results:
- Ten children (6 boys, 4 girls) underwent tumor resection at a median age of 2 years and 3 months.
- Tumor locations included trunk, groin, perineum, and omentum.
- Two patients experienced local recurrence, requiring secondary resection 2 and 6 years post-initial surgery.
Conclusions:
- Increased awareness of lipoblastoma aids in optimal imaging and surgical planning.
- Complete, non-mutilating surgical resection is the primary treatment.
- Long-term follow-up (up to 10 years) is necessary due to the possibility of late recurrences; MRI is recommended for follow-up.
